US equities
|
NVDA
$204.64
▼-4.22%
INTC
$65.76
▼-28.58%
MU
$884.79
▼-5.30%
AMZN
$240.35
▼-1.41%
AAPL
$344.63
▼-1.23%
SNDK
$1,150.89
▼-13.47%
AMD
$504.80
▼-10.88%
GOOGL
$279.84
▼-1.40%
NVDA
$204.64
▼-4.22%
INTC
$65.76
▼-28.58%
MU
$884.79
▼-5.30%
AMZN
$240.35
▼-1.41%
AAPL
$344.63
▼-1.23%
SNDK
$1,150.89
▼-13.47%
AMD
$504.80
▼-10.88%
GOOGL
$279.84
▼-1.40%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about CAR T/cell Therapy
Recent news which mentions CAR T/cell Therapy
Gilead Sciences: U.S. Military Veteran Battles Lymphoma With Car T-Cell Therapy: Marcus' Story
December 08, 2022
Tags
NYSE:GILD
Health & Healthcare
CAR T/cell Therapy
From
3BL Media: Corporate Social Responsibility, Energy and Health News
Overcoming Blood Cancer With CAR T-cell Therapy: Eleonora's Journey
September 07, 2022
Tags
non/Hodgkin lymphoma
NYSE:GILD
Health & Healthcare
From
3BL Media: Corporate Social Responsibility, Energy and Health News
Mom Celebrates Sons' Milestones: Julie's CAR T-cell Therapy Journey
April 20, 2022
Tags
Gilead
NYSE:GILD
CAR T/cell Therapy
From
3BL Media: Corporate Social Responsibility, Energy and Health News